More efficient clinical trials may reduce global CRO revenue, potentially slowing adoption of new technology, says Ostuka director – noting that the industry doesn’t often take operational risks, but it must.
BiondVax is working closely with a CRO to advance its universal flu vaccine candidate, which will be manufactured in-house and in collaboration with a CMO to support tech-transfer pending a successful trial.
Bristol-Myers Squibb is conducting a pilot program through which it will use GRYT Health’s mobile app to collect real-world data – with the goal of improving clinical trial design and patient wellbeing.
The non-clinical contract research organization (CRO) Citoxlab Group has acquired Solvo Biotechnology, a CRO specializing in drug transporters studies and the assessment of drug-drug interactions (DDI).
Trans-Hit Bio and Q&T Research have entered into an exclusive strategic partnership, which will provide biopharma customers with access to human biospecimens, for which there is “a great demand,” says exec.